Pfizer Inc. confirmed on Thursday that it is in “preliminary friendly discussions” regarding a potential merger with Allergan PLC . The drug giant said no deal has been reached, and there can be no certainty that current talks will lead to a deal. Pfizer said it would not comment regarding terms of a potential transaction. The news of a potential deal, which would be the biggest merger of the year, was first reported by The Wall Street Journal. Earlier Thursday, Allergan confirmed that it had been approached by Pfizer regarding a potential deal. Shares of Pfizer and Allergan remain halted since just before the market opened.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News